Bone Marrow TransplantationTransplantation, HomologousGraft vs Host DiseaseBone MarrowBone Marrow CellsTransplantation, AutologousTransplantation ConditioningHematopoietic Stem Cell TransplantationWhole-Body IrradiationTransplantation ChimeraLeukemiaAnemia, AplasticTissue DonorsLiver TransplantationGraft SurvivalBusulfanHistocompatibility TestingHistocompatibilityRecurrenceLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTransplantation, IsogeneicHematologic NeoplasmsGraft vs Tumor EffectKidney TransplantationCyclophosphamideLeukemia, Myeloid, AcuteRemission InductionImmunosuppressive AgentsLeukocyte TransfusionPrecursor Cell Lymphoblastic Leukemia-LymphomaBone and BonesHematopoietic Stem CellsBone Marrow PurgingLymphocyte DepletionRadiation ChimeraGraft RejectionTreatment OutcomeTransplantation ImmunologyGraft vs Host ReactionAcute DiseaseGraft vs Leukemia EffectCombined Modality TherapyStem Cell TransplantationHepatic Veno-Occlusive DiseaseImmunosuppressionMice, Inbred C57BLLeukemia, MyeloidTime FactorsLymphocyte TransfusionHematopoiesisT-LymphocytesMyelodysplastic SyndromesHeart TransplantationSurvival AnalysisCyclosporineRetrospective StudiesNuclear FamilyChimeraHLA AntigensBone Marrow DiseasesLung TransplantationLymphoma, Non-HodgkinActuarial AnalysisCytomegalovirus InfectionsSurvival RateHematologic DiseasesSevere Combined ImmunodeficiencyGranulocyte Colony-Stimulating FactorMice, Inbred BALB CAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesDisease-Free SurvivalOrgan TransplantationBone Marrow ExaminationMultiple MyelomaPeripheral Blood Stem Cell TransplantationFatal OutcomeCytarabineLymphomaSpleenBone Marrow NeoplasmsPancytopeniaColony-Forming Units AssayLeukocyte CountAntigens, CD34Cord Blood Stem Cell TransplantationSkin TransplantationNeoplasm, ResidualIslets of Langerhans TransplantationPrognosisMelphalanCell TransplantationAntilymphocyte SerumSalvage TherapyInfectionEtoposidePancreas TransplantationTransplantation ToleranceLife TablesFlow Cytometry